EA201201252A1 - SOLID MEDICAL FORM, possessing a gastrointestinal action (options) - Google Patents
SOLID MEDICAL FORM, possessing a gastrointestinal action (options)Info
- Publication number
- EA201201252A1 EA201201252A1 EA201201252A EA201201252A EA201201252A1 EA 201201252 A1 EA201201252 A1 EA 201201252A1 EA 201201252 A EA201201252 A EA 201201252A EA 201201252 A EA201201252 A EA 201201252A EA 201201252 A1 EA201201252 A1 EA 201201252A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- action
- solid dosage
- possessing
- options
- therapeutic effect
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к области фармацевтической промышленности и медицине и может быть использовано при создании и применении твердых лекарственных форм, обладающих желчегонным действием. Задачей настоящего изобретения является создание эффективной твердой лекарственной формы, обладающей желчегонным действием. В описании заявлено два варианта изобретения, у которых задача решается за счет того, что твердая лекарственная форма содержит высушенную желчь, минеральные вещества, фармацевтически приемлемое углеродсодержащее дополнительное вещество с изотопами углеродаС. Техническими результатами изобретения являются увеличение лечебного эффекта, увеличение скорости наступления лечебного эффекта при сохранении продолжительности действия без увеличения концентрации желчи при лечении заболеваний печени и желчного пузыря.The invention relates to the field of pharmaceutical industry and medicine and can be used to create and use solid dosage forms with choleretic action. The present invention is the creation of an effective solid dosage form with choleretic action. The description claims two variants of the invention, in which the problem is solved due to the fact that the solid dosage form contains dried bile, minerals, a pharmaceutically acceptable carbon-containing additional substance with carbon isotopes. The technical results of the invention are to increase the therapeutic effect, increase the speed of the onset of the therapeutic effect while maintaining the duration of action without increasing the concentration of bile in the treatment of diseases of the liver and gallbladder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201201252A EA020149B1 (en) | 2012-10-04 | 2012-10-04 | Solid dosage form having a choleretic effect (variants) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201201252A EA020149B1 (en) | 2012-10-04 | 2012-10-04 | Solid dosage form having a choleretic effect (variants) |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201201252A1 true EA201201252A1 (en) | 2014-04-30 |
EA020149B1 EA020149B1 (en) | 2014-09-30 |
Family
ID=50516421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201201252A EA020149B1 (en) | 2012-10-04 | 2012-10-04 | Solid dosage form having a choleretic effect (variants) |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA020149B1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2335925C2 (en) * | 2006-04-12 | 2008-10-20 | Антон Викторович Сергеев | Biologically active preparation and method of its manufacturing |
CN101053571A (en) * | 2006-04-13 | 2007-10-17 | 魏秀华 | Gentiopicroside drop pill and preparation method thereof |
-
2012
- 2012-10-04 EA EA201201252A patent/EA020149B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA020149B1 (en) | 2014-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201401028A1 (en) | PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY | |
MX2016005532A (en) | Methods for using nitric oxide in a plasma state to treat medical conditions and diseases. | |
EA201690754A1 (en) | APPLICATION OF PCSK9 INHIBITOR FOR THE TREATMENT OF HYPERLIPIDEMIA | |
BR112015010477A2 (en) | A pharmaceutical combination comprising a b-raf inhibitor and a histone deacetylase inhibitor and their use in the treatment of proliferative diseases. | |
PH12017502046A1 (en) | Salts and prodrugs of 1-methyl-d-tryptophan | |
EA201591603A1 (en) | NEW THERAPEUTIC COMBINATIONS MYRTAZAPINE FOR APPLICATION IN PAIN DISEASES | |
BR112015007095A8 (en) | dihydro-6-azafenalene derivatives for the treatment of snc, oncological diseases and related disorders, pharmaceutical composition comprising them and use of said derivatives | |
EA201201252A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201201256A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201201251A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201201255A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201201250A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201201257A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201201249A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201201248A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201201253A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201201254A1 (en) | SOLID MEDICAL FORM, possessing a gastrointestinal action (options) | |
EA201200464A1 (en) | SOLID MEDICINE FORM WITH A FUNNY RELIEF, LOCAL ENVIRONMENT AND ANTI-INFLAMMATORY ACTION (OPTIONS) | |
EA201200450A1 (en) | SOLID MEDICINE FORM WITH A FUNNY RELIEF, LOCAL ENVIRONMENT AND ANTI-INFLAMMATORY ACTION (OPTIONS) | |
EA201200448A1 (en) | SOLID MEDICINE FORM WITH A FUNNY RELIEF, LOCAL ENVIRONMENT AND ANTI-INFLAMMATORY ACTION (OPTIONS) | |
EA201592261A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING AGOMELATIN IN THE FORM OF HOMELATIN CRYSTALS WITH ORGANIC ACID | |
EA201200451A1 (en) | SOLID MEDICINE FORM WITH A FUNNY RELIEF, LOCAL ENVIRONMENT AND ANTI-INFLAMMATORY ACTION (OPTIONS) | |
EA201200462A1 (en) | SOLID MEDICINE FORM WITH A FUNNY RELIEF, LOCAL ENVIRONMENT AND ANTI-INFLAMMATORY ACTION (OPTIONS) | |
EA201200463A1 (en) | SOLID MEDICINE FORM WITH A FUNNY RELIEF, LOCAL ENVIRONMENT AND ANTI-INFLAMMATORY ACTION (OPTIONS) | |
EA201200446A1 (en) | SOLID MEDICINE FORM WITH A FUNNY RELIEF, LOCAL ENVIRONMENT AND ANTI-INFLAMMATORY ACTION (OPTIONS) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |